CFRX Price Targets and Analyst Ratings NASDAQ:CFRX
CFRX Forecast. What You Should Know.
CFRX Historical Ratings and Targets
About ContraFect Corporation
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.